Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis Inc (NQ: EXEL ) 25.73 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Exelixis Inc < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > 3 Stocks to Buy for a Soft Landing, If There Is One August 15, 2024 Recent economic data is reigniting talk about a soft landing for the economy; here are three stocks to consider if a soft landing materializes Via MarketBeat Topics Economy Exposures Economy Interest Rates NASDAQ:EXEL, an undervalued stock with good fundamentals. August 15, 2024 Don't overlook EXELIXIS INC (NASDAQ:EXEL)—it's a hidden gem with strong fundamentals and an attractive price tag. Via Chartmill Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review August 09, 2024 After Monday's panicked global sell-off, markets have calmed down. Via Investor's Business Daily Expert Outlook: Exelixis Through The Eyes Of 5 Analysts August 08, 2024 Via Benzinga The Analyst Verdict: Exelixis In The Eyes Of 5 Experts May 01, 2024 Via Benzinga Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results August 07, 2024 Exelixis reports strong Q2 earnings with adjusted EPS of $0.84, surpassing estimates. The CONTACT-02 trial for mCRPC showed significant PFS benefit but OS did not achieve statistical significance.... Via Benzinga Exposures Product Safety US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity' August 07, 2024 Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by... Via Benzinga Topics Stocks Exposures US Equities Exelixis (EXEL) Q2 2024 Earnings Call Transcript August 07, 2024 EXEL earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial EXEL Stock Earnings: Exelixis Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 EXEL stock results show that Exelixis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Exelixis Announces Second Quarter 2024 Financial Results and Provides Corporate Update August 06, 2024 From Exelixis, Inc. Via Business Wire Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday? August 06, 2024 U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offsetting Monday’s losses. Investors took advantage of recent volatility to buy... Via Benzinga Topics Economy Stocks Exposures Economy US Equities Exelixis Announces U.S. Food and Drug Administration (FDA) Accepted the Supplemental New Drug Application for Cabozantinib for Patients with Advanced Neuroendocrine Tumors August 06, 2024 From Exelixis, Inc. Via Business Wire US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction August 06, 2024 Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainability of uptrend. Via Benzinga Topics Stocks Exposures US Equities Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 July 23, 2024 From Exelixis, Inc. Via Business Wire In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. July 18, 2024 EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying. Via Chartmill 7 Cheap Biotech Stocks With Major Upside Potential July 09, 2024 While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks. Via InvestorPlace When you look at NASDAQ:EXEL, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. June 27, 2024 When you look at EXELIXIS INC (NASDAQ:EXEL), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. Via Chartmill Don't overlook NASDAQ:EXEL—it's a hidden gem with strong fundamentals and an attractive price tag. June 06, 2024 EXELIXIS INC (NASDAQ:EXEL) appears to be flying under the radar despite its strong fundamentals. Via Chartmill 10 Health Care Stocks Whale Activity In Today's Session May 31, 2024 Via Benzinga Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying May 31, 2024 Via Benzinga Exelixis to Present at the William Blair 44th Annual Growth Stock Conference May 28, 2024 From Exelixis, Inc. Via Business Wire Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA May 20, 2024 From Exelixis, Inc. Via Business Wire In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. May 15, 2024 For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. Via Chartmill Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You? May 12, 2024 These stocks are both experts in their respective fields. Via The Motley Fool MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths' May 10, 2024 Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets. Via Benzinga Just Say No to Drugs: 3 Pharma Stocks to Avoid May 08, 2024 Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios. Via InvestorPlace Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May May 07, 2024 From Exelixis, Inc. Via Business Wire Exelixis (EXEL) Q1 2024 Earnings Call Transcript May 01, 2024 EXEL earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial EXEL Stock Earnings: Exelixis Misses EPS, Misses Revenue for Q1 2024 April 30, 2024 EXEL stock results show that Exelixis missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update April 30, 2024 From Exelixis, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.